QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-reiterates-hold-on-staar-surgical

Needham analyst David Saxon reiterates Staar Surgical (NASDAQ:STAA) with a Hold.

 canaccord-genuity-maintains-hold-on-staar-surgical-lowers-price-target-to-43

Canaccord Genuity analyst Jon Young maintains Staar Surgical (NASDAQ:STAA) with a Hold and lowers the price target from $46 ...

 piper-sandler-maintains-neutral-on-staar-surgical-raises-price-target-to-40

Piper Sandler analyst Matt O'Brien maintains Staar Surgical (NASDAQ:STAA) with a Neutral and raises the price target fro...

 mizuho-maintains-buy-on-staar-surgical-raises-price-target-to-55

Mizuho analyst Anthony Petrone maintains Staar Surgical (NASDAQ:STAA) with a Buy and raises the price target from $53 to $55.

 staar-surgical-announces-strategic-agreement-with-iq-laser-vision-in-us

Agreement is Largest Commitment to EVO ICL™ in the U.S.STAAR Surgical Company (NASDAQ:STAA), a leading developer, manufacturer ...

 staar-surgical-q1-2024-gaap-eps-007-beats-011-estimate

Staar Surgical (NASDAQ:STAA) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.11...

 apple-to-210-here-are-10-top-analyst-forecasts-for-thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 mizuho-maintains-buy-on-staar-surgical-raises-price-target-to-53

Mizuho analyst Anthony Petrone maintains Staar Surgical (NASDAQ:STAA) with a Buy and raises the price target from $45 to $53.

 canaccord-genuity-maintains-hold-on-staar-surgical-raises-price-target-to-46

Canaccord Genuity analyst Jon Young maintains Staar Surgical (NASDAQ:STAA) with a Hold and raises the price target from $32 ...

 eye-lens-maker-staar-surgical-expects-q1-sales-to-beat-consensus

STAAR Surgical reports Q1 2024 net sales surpassing $77 million, with U.S. ICL sales hitting $5 million, the highest since FDA ...

 why-staar-surgical-shares-are-trading-higher-by-around-13-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong prelimi...

 needham-reiterates-hold-on-staar-surgical

Needham analyst David Saxon reiterates Staar Surgical (NASDAQ:STAA) with a Hold.

Core News & Articles
Market-Moving News for April 4th
04/04/2024 12:33:04

TVGN: 101% | Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development CADL: 62% | Candel Ther...

 staar-surgical-reports-preliminary-net-sales-for-q1-to-be-in-excess-of-77m-est-72134m-now-expects-fy24-net-sales-can-be-at-higher-end-of-prior-outlook-range-of-335m-340m-est-337208m

U.S. ICL sales expected to be $5 million for the quarter. This represents the Company's highest quarterly ICL sales in the ...

 stifel-maintains-buy-on-staar-surgical-maintains-50-price-target

Stifel analyst Thomas Stephan maintains Staar Surgical (NASDAQ:STAA) with a Buy and maintains $50 price target.

 why-mesoblast-shares-are-trading-higher-by-13-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an ...

 netflix-to-rally-around-20-here-are-10-top-analyst-forecasts-for-monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION